BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9687844)

  • 21. [Updated STIKO vaccination recommendations published].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2013 Sep; 36(9):317. PubMed ID: 24069644
    [No Abstract]   [Full Text] [Related]  

  • 22. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desirability and feasibility of hepatitis B vaccine in EPI.
    Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
    [No Abstract]   [Full Text] [Related]  

  • 25. WHO targets measles and hepatitis B in Western Pacific.
    Benitez MA
    Lancet; 2003 Sep; 362(9389):1048. PubMed ID: 14526777
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 May; 32(5):609-13. PubMed ID: 8613328
    [No Abstract]   [Full Text] [Related]  

  • 27. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of hepatitis B virus immunization.
    Sharfstein J; Wise P
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598611
    [No Abstract]   [Full Text] [Related]  

  • 30. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa.
    Schoub BD; Matai U; Singh B; Blackburn NK; Levin JB
    Bull World Health Organ; 2002; 80(4):277-81. PubMed ID: 12075363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?
    Ganiats TG; Bowersox MT; Ralph LP
    J Fam Pract; 1993 Feb; 36(2):147-9. PubMed ID: 8426132
    [No Abstract]   [Full Text] [Related]  

  • 32. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 33. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian].
    Li L; Zhou Y; Zhao L; Xia S; Wang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B immunization schedule recommended by IAP.
    Paul Y
    Indian Pediatr; 2002 May; 39(5):503-4; author reply 504-5. PubMed ID: 12037289
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continue to vaccinate against hepatitis B.
    Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
    Chauvin P; Ekra D; Plotkin SA
    Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
    [No Abstract]   [Full Text] [Related]  

  • 38. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union].
    Magdzik W
    Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001
    [No Abstract]   [Full Text] [Related]  

  • 39. Universal hepatitis B vaccination.
    Hahné S; Ramsay M; Coutinho R
    Lancet Infect Dis; 2008 Feb; 8(2):87-8; author reply 90. PubMed ID: 18222157
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis B vaccination of neonates].
    Mutz I
    Padiatr Padol; 1993; 28(2):A11-2. PubMed ID: 8479769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.